High dose tranylcypromine withdrawal with delirium and thrombocytopenia, effect of physostigmine

High dose tranylcypromine withdrawal with delirium and thrombocytopenia, effect of physostigmine

A 37-year-old male with a history of polyvalent drug abuse (heroin, amphetamines, alcohol), but abstinent for six years, was prescribed 40 mg tranylcypromine daily because of migraine by his neurologist. Tranylcypromine relieved the migraine, but had an additional "peculiar effect" in that...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical toxicology (Philadelphia, Pa.) Pa.), 2006-04, Vol.44 (4), p.499-499
Hauptverfasser: Pfab, R, Eyer, F, Jetzinger, E, Zilker, Th
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 499
container_issue 4
container_start_page 499
container_title Clinical toxicology (Philadelphia, Pa.)
container_volume 44
creator Pfab, R
Eyer, F
Jetzinger, E
Zilker, Th
description A 37-year-old male with a history of polyvalent drug abuse (heroin, amphetamines, alcohol), but abstinent for six years, was prescribed 40 mg tranylcypromine daily because of migraine by his neurologist. Tranylcypromine relieved the migraine, but had an additional "peculiar effect" in that he could "concentrate better", "think more clearly" and felt "less distracted by daily worries." He increased the dose to 240 mg daily. After twelve weeks of this high dose consumption and several collapses he stopped the consumption and became delirious. He was admitted to psychiatry. Within two days the delirium worsened, he became combative and was transferred to our facility after sedation with diazepam. On arrival, he talked to imaginary policemen in English language (although a native German speaker) before he started to sing.
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_17262368</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17262368</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_172623683</originalsourceid><addsrcrecordid>eNqNjUsOgjAURTvQRPzs4Y0cScJHEMdGwwKcay0PWlNa7Csh7F40LsDRuYOTe2YsiLMsD9M8ixZsSfSMorTYH-OA3UvVSKgsIXjHzajF2DnbKoMwKC8rxweuvxMq1MqpvgVuKvBysh5WjN52aBTfAdY1Cg-2hk6OZMmr5nOzZvOaa8LNjyu2vZyvpzKcMq8eyd9aRQK15gZtT7f4kORJmhfp3-IbGztJEQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17262368</pqid></control><display><type>article</type><title>High dose tranylcypromine withdrawal with delirium and thrombocytopenia, effect of physostigmine</title><source>Taylor &amp; Francis Medical Library - CRKN</source><source>Taylor &amp; Francis Journals Complete</source><creator>Pfab, R ; Eyer, F ; Jetzinger, E ; Zilker, Th</creator><creatorcontrib>Pfab, R ; Eyer, F ; Jetzinger, E ; Zilker, Th</creatorcontrib><description>A 37-year-old male with a history of polyvalent drug abuse (heroin, amphetamines, alcohol), but abstinent for six years, was prescribed 40 mg tranylcypromine daily because of migraine by his neurologist. Tranylcypromine relieved the migraine, but had an additional "peculiar effect" in that he could "concentrate better", "think more clearly" and felt "less distracted by daily worries." He increased the dose to 240 mg daily. After twelve weeks of this high dose consumption and several collapses he stopped the consumption and became delirious. He was admitted to psychiatry. Within two days the delirium worsened, he became combative and was transferred to our facility after sedation with diazepam. On arrival, he talked to imaginary policemen in English language (although a native German speaker) before he started to sing.</description><identifier>ISSN: 1556-3650</identifier><language>eng</language><ispartof>Clinical toxicology (Philadelphia, Pa.), 2006-04, Vol.44 (4), p.499-499</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Pfab, R</creatorcontrib><creatorcontrib>Eyer, F</creatorcontrib><creatorcontrib>Jetzinger, E</creatorcontrib><creatorcontrib>Zilker, Th</creatorcontrib><title>High dose tranylcypromine withdrawal with delirium and thrombocytopenia, effect of physostigmine</title><title>Clinical toxicology (Philadelphia, Pa.)</title><description>A 37-year-old male with a history of polyvalent drug abuse (heroin, amphetamines, alcohol), but abstinent for six years, was prescribed 40 mg tranylcypromine daily because of migraine by his neurologist. Tranylcypromine relieved the migraine, but had an additional "peculiar effect" in that he could "concentrate better", "think more clearly" and felt "less distracted by daily worries." He increased the dose to 240 mg daily. After twelve weeks of this high dose consumption and several collapses he stopped the consumption and became delirious. He was admitted to psychiatry. Within two days the delirium worsened, he became combative and was transferred to our facility after sedation with diazepam. On arrival, he talked to imaginary policemen in English language (although a native German speaker) before he started to sing.</description><issn>1556-3650</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNjUsOgjAURTvQRPzs4Y0cScJHEMdGwwKcay0PWlNa7Csh7F40LsDRuYOTe2YsiLMsD9M8ixZsSfSMorTYH-OA3UvVSKgsIXjHzajF2DnbKoMwKC8rxweuvxMq1MqpvgVuKvBysh5WjN52aBTfAdY1Cg-2hk6OZMmr5nOzZvOaa8LNjyu2vZyvpzKcMq8eyd9aRQK15gZtT7f4kORJmhfp3-IbGztJEQ</recordid><startdate>20060401</startdate><enddate>20060401</enddate><creator>Pfab, R</creator><creator>Eyer, F</creator><creator>Jetzinger, E</creator><creator>Zilker, Th</creator><scope>7T2</scope><scope>7U2</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20060401</creationdate><title>High dose tranylcypromine withdrawal with delirium and thrombocytopenia, effect of physostigmine</title><author>Pfab, R ; Eyer, F ; Jetzinger, E ; Zilker, Th</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_172623683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pfab, R</creatorcontrib><creatorcontrib>Eyer, F</creatorcontrib><creatorcontrib>Jetzinger, E</creatorcontrib><creatorcontrib>Zilker, Th</creatorcontrib><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Clinical toxicology (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pfab, R</au><au>Eyer, F</au><au>Jetzinger, E</au><au>Zilker, Th</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High dose tranylcypromine withdrawal with delirium and thrombocytopenia, effect of physostigmine</atitle><jtitle>Clinical toxicology (Philadelphia, Pa.)</jtitle><date>2006-04-01</date><risdate>2006</risdate><volume>44</volume><issue>4</issue><spage>499</spage><epage>499</epage><pages>499-499</pages><issn>1556-3650</issn><abstract>A 37-year-old male with a history of polyvalent drug abuse (heroin, amphetamines, alcohol), but abstinent for six years, was prescribed 40 mg tranylcypromine daily because of migraine by his neurologist. Tranylcypromine relieved the migraine, but had an additional "peculiar effect" in that he could "concentrate better", "think more clearly" and felt "less distracted by daily worries." He increased the dose to 240 mg daily. After twelve weeks of this high dose consumption and several collapses he stopped the consumption and became delirious. He was admitted to psychiatry. Within two days the delirium worsened, he became combative and was transferred to our facility after sedation with diazepam. On arrival, he talked to imaginary policemen in English language (although a native German speaker) before he started to sing.</abstract></addata></record>
fulltext fulltext
identifier ISSN: 1556-3650
ispartof Clinical toxicology (Philadelphia, Pa.), 2006-04, Vol.44 (4), p.499-499
issn 1556-3650
language eng
recordid cdi_proquest_miscellaneous_17262368
source Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete
title High dose tranylcypromine withdrawal with delirium and thrombocytopenia, effect of physostigmine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T14%3A18%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20dose%20tranylcypromine%20withdrawal%20with%20delirium%20and%20thrombocytopenia,%20effect%20of%20physostigmine&rft.jtitle=Clinical%20toxicology%20(Philadelphia,%20Pa.)&rft.au=Pfab,%20R&rft.date=2006-04-01&rft.volume=44&rft.issue=4&rft.spage=499&rft.epage=499&rft.pages=499-499&rft.issn=1556-3650&rft_id=info:doi/&rft_dat=%3Cproquest%3E17262368%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17262368&rft_id=info:pmid/&rfr_iscdi=true